Delivery Order SPE2DB24D1021-SPE2DB25FEWUS

Award Date 5/14/25
Potential Completion Date 6/5/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,485.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,886,444 vials of the drug ZILRETTA 32 MG. The contract has a period of performance through May 2, 2025 and was awarded on April 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $5,258.55 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 32 mg ZILRETTA vials, a specialty medication, to support federal healthcare programs. The order has an ultimate completion date of August 14, 2024. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,457.88 firm fixed-price delivery order is for the supply of 4,568,236,556 vials of the medication ZILRETTA 32 MG. The contract has a performance period extending through June 4, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This contract award, valued at $1,857.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILRETTA 32 MG VIALS, a medical product, with a completion date of April 15, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,813.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZILRETTA 32 MG VIALS, a medical product. The contract has an ultimate completion date of January 10, 2025, and a firm fixed-price pricing type. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILRETTA 32 MG VIALS, a specialty medication, with a ceiling value of $1,905.39 and a completion date of January 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.90 firm fixed price delivery order is for the supply of 4,568,152,966 units of ZILRETTA 32 MG VIALS. The contract has an ultimate completion date of May 28, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award, valued at $5,572.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILRETTA 32 MG VIALS, a medical product, with an ultimate completion date of January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,450.76 firm fixed-price delivery order is for the supply of 32 mg vials of the drug ZILRETTA. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,485.96. It is not a set-aside contract, indicating open competition. The contract appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWUS
    Delivery Order

This is a $1,857.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,246,627 vials of the drug ZILRETTA 32 MG. The contract has a period of performance through June 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract. The contract supports federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/13/25, 10:44 AM